• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.89% Nasdaq Up 1.18%

    More On BIOCON.NS

    Quotes

    Charts

    News & Info

    Company

    Analyst Coverage

    Ownership

    • Major Holders
    • Insider Transactions
    • Insider Roster

    Financials

    Biocon Limited (BIOCON.NS)

    -NSE
    424.50 Down 4.55(1.06%) 4:59AM EST
    Add to Portfolio
    Prev Close:429.05
    Open:426.15
    Bid:N/A
    Ask:424.50
    1y Target Est:N/A
    Beta:N/A
    Next Earnings Date:N/A
    Day's Range:407.90 - 428.00
    52wk Range:394.05 - 553.60
    Volume:1,051,248
    Avg Vol (3m):766,722
    Market Cap:83.31B
    P/E (ttm):20.03
    EPS (ttm):21.20
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in INR.

    Key Statistics

    Forward P/E (1 yr):16.37
    P/S (ttm):2.89
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Mar-15) :21.89
    Quarterly EPS Est (Dec-14) :5.54
    Mean Recommendation*:2.9
    PEG Ratio (5 yr expected):1.53

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Biocon Limited develops and sells biotechnology products for the pharmaceutical sector in India and internationally. It offers active pharmaceutical ingredients, including cardiovascular agents, anti-obesity agents, immunosuppressants, opthalmics,... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback